home · filing · 0000950170-23-066108
8-K
filed November 27, 2023, 6:59 PM ET
ticker INGN
CIK 0001294133
leadership
confidence high
sentiment neutral
materiality 0.65
Inogen officer Nabil Shabshab separates; receives $1.4M severance, resigns from board
Inogen Inc
Shabshab's employment ended Nov 10, 2023; entered separation agreement on Nov 22, 2023.
Severance of $1.4M paid over 24 months at $58,333.33/month, plus 24-month COBRA reimbursement.
Equity awards eligible for double-trigger vesting acceleration if change of control within 3 months after separation.
Retains $8,053 in airfare credits; resigns from board effective Nov 22, 2023, no disagreement with company.
Reaffirms confidentiality obligations; returns company property; assigns inventions to Inogen.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Nabil Shabshab
Director
Effective 2023-11-22
Filed November 27, 2023, 6:59 PM ET
Mr. Shabshab resigned from the Company’s board of directors, effective as of November 22, 2023
Departed
Nabil Shabshab
Other Named Officer
Effective 2023-11-10
Filed November 27, 2023, 6:59 PM ET
Mr. Shabshab’s role as an officer and employee of the Company ended effective November 10, 2023
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Nabil Shabshab resigned as Director at Inogen Inc.
Action resigned
Role Director
Exact text from the filing
Mr. Shabshab resigned from the Company’s board of directors, effective as of November 22, 2023
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Nabil Shabshab departed as other_named_officer at Inogen Inc.
Action ended
Exact text from the filing
Mr. Shabshab’s role as an officer and employee of the Company ended effective November 10, 2023
View on SEC.gov
Source: SEC EDGAR
accession 0000950170-23-066108
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.